Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13
Corrigendum
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
2,356 | Dovepress* | 2,280+ | 315 | 2,595 | |
PubMed Central* | 76 | 41 | 117 | ||
Totals | 2,356 | 356 | 2,712 | ||
*Since 14 July 2021 |
View citations on PubMed and Google Scholar